Dr. Sheng Guo leads the Data Science and Bioinformatics team at Crown Bioscience, bringing with him extensive experience from his previous roles at Boehringer Ingelheim Pharmaceutical Inc. and Syngenta.
Dr. Guo’s current research interests are tumor model omics, preclinical statistics, biomarker discovery, NGS product design, AI imaging analysis, and bioinformatics software development. Dr. Guo has authored more than 50 abstracts and manuscripts, with recent major-author papers in Cancer Research, Cancer Research Communications, NAR Genomics and Bioinformatics, and BMC Cancer, amongst others.
Dr. Guo received his PhD in Genomics and Computational Biology from the University of Pennsylvania, and his BSc in Biochemistry from Nankai University.
Current role